SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-010030
Filing Date
2018-01-12
Accepted
2018-01-12 16:11:56
Documents
3
Period of Report
2018-01-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d521281d8k.htm 8-K 15044
2 EX-10.1 d521281dex101.htm EX-10.1 202397
3 GRAPHIC g521281g89t28.jpg GRAPHIC 6737
  Complete submission text file 0001193125-18-010030.txt   228147
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36500 | Film No.: 18526106
SIC: 2834 Pharmaceutical Preparations